Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9642900rdf:typepubmed:Citationlld:pubmed
pubmed-article:9642900lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0038436lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0001758lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0333052lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C0348000lld:lifeskim
pubmed-article:9642900lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:9642900pubmed:issue3lld:pubmed
pubmed-article:9642900pubmed:dateCreated1998-8-4lld:pubmed
pubmed-article:9642900pubmed:abstractTextThe presence of a posttraumatic stress disorder (PTSD) diagnosis in women (n = 82) diagnosed with Stage 0-IIIA breast cancer was assessed 6 to 72 months after cancer therapy. The PTSD Checklist-Civilian Version (PCL-C) and the PTSD module for the Structured Clinical Interview for DSM-IV, Nonpatient Version, PTSD module (SCID-NP-PTSD) were administered in a telephone interview. SCID-NP-PTSD results indicated prevalence rates of 6% and 4% for current and lifetime PTSD, respectively. Use of the recommended cutoff score of 50 on the PCL-C to determine diagnosis of current cancer-related PTSD resulted in a sensitivity of .60 and a specificity of .99 with 2 false-negative diagnoses. In conclusion, PTSD can be precipitated by diagnosis and treatment of breast cancer, and the PCL-C can be a cost-effective screening tool for this disorder.lld:pubmed
pubmed-article:9642900pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9642900pubmed:languageenglld:pubmed
pubmed-article:9642900pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9642900pubmed:citationSubsetIMlld:pubmed
pubmed-article:9642900pubmed:statusMEDLINElld:pubmed
pubmed-article:9642900pubmed:monthJunlld:pubmed
pubmed-article:9642900pubmed:issn0022-006Xlld:pubmed
pubmed-article:9642900pubmed:authorpubmed-author:MillerT WTWlld:pubmed
pubmed-article:9642900pubmed:authorpubmed-author:AndrykowskiM...lld:pubmed
pubmed-article:9642900pubmed:authorpubmed-author:StudtsJ LJLlld:pubmed
pubmed-article:9642900pubmed:authorpubmed-author:CordovaM JMJlld:pubmed
pubmed-article:9642900pubmed:issnTypePrintlld:pubmed
pubmed-article:9642900pubmed:volume66lld:pubmed
pubmed-article:9642900pubmed:ownerNLMlld:pubmed
pubmed-article:9642900pubmed:authorsCompleteYlld:pubmed
pubmed-article:9642900pubmed:pagination586-90lld:pubmed
pubmed-article:9642900pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:meshHeadingpubmed-meshheading:9642900-...lld:pubmed
pubmed-article:9642900pubmed:year1998lld:pubmed
pubmed-article:9642900pubmed:articleTitlePosttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD Checklist-Civilian Version (PCL-C) as a screening instrument.lld:pubmed
pubmed-article:9642900pubmed:affiliationDepartment of Behavioral Science, University of Kentucky College of Medicine, Lexington 40536-0086, USA. mandry@pop.uky.edulld:pubmed
pubmed-article:9642900pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9642900pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9642900pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9642900lld:pubmed